ARTICLE | Clinical News
Hemopure hemoglobin glutamer regulatory update
March 20, 2006 8:00 AM UTC
FDA said it would consult an advisory committee within 6 months to discuss the Phase IIb/III RESUS trial that was put on clinical hold last year. The agency requested dosing instructions for administe...